18 March 2016 Advances towards reliable identification and concentration determination of rare cells in peripheral blood
Author Affiliations +
Abstract
Through further development, integration and validation of micro-nano-bio and biophotonics systems FP7 CanDo is developing an instrument that will permit highly reproducible and reliable identification and concentration determination of rare cells in peripheral blood for two key societal challenges, early and low cost anti-cancer drug efficacy determination and cancer diagnosis/monitoring.

A cellular link between the primary malignant tumour and the peripheral metastases, responsible for 90% of cancerrelated deaths, has been established in the form of circulating tumour cells (CTCs) in peripheral blood. Furthermore, the relatively short survival time of CTCs in peripheral blood means that their detection is indicative of tumour progression thereby providing in addition to a prognostic value an evaluation of therapeutic efficacy and early recognition of tumour progression in theranostics. In cancer patients however blood concentrations are very low (=1 CTC/1E9 cells) and current detection strategies are too insensitive, limiting use to prognosis of only those with advanced metastatic cancer. Similarly, problems occur in therapeutics with anti-cancer drug development leading to lengthy and costly trials often preventing access to market.

The novel cell separation/Raman analysis technologies plus nucleic acid based molecular characterization of the CanDo platform will provide an accurate CTC count with high throughput and high yield meeting both key societal challenges. Being beyond the state of art it will lead to substantial share gains not just in the high end markets of drug discovery and cancer diagnostics but due to modular technologies also in others. Here we present preliminary DNA hybridization sensing results.
Conference Presentation
© (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
R. Alemany Server, R. Alemany Server, D. Martens, D. Martens, K. Jans, K. Jans, P. Bienstman, P. Bienstman, D. Hill, D. Hill, } "Advances towards reliable identification and concentration determination of rare cells in peripheral blood", Proc. SPIE 9705, Microfluidics, BioMEMS, and Medical Microsystems XIV, 97050G (18 March 2016); doi: 10.1117/12.2218621; https://doi.org/10.1117/12.2218621
PROCEEDINGS
8 PAGES + PRESENTATION

SHARE
Back to Top